Bristol-Myers Squibb Company (BMY)

BMY (NYSE:Drugs) EQUITY
$56.64
pos +0.00
+0.00%
Today's Range: 56.24 - 57.36 | BMY Avg Daily Volume: 8,369,500
Last Update: 06/23/17 - 4:00 PM EDT
Volume: 0
YTD Performance: -3.08%
Open: $0.00
Previous Close: $57.33
52 Week Range: $46.01 - $77.12
Oustanding Shares: 1,647,434,458
Market Cap: 94,447,417,477
6-Month Chart
TheStreet Ratings Grade for BMY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 5 6 6 6
Moderate Buy 1 1 1 1
Hold 6 6 6 6
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 2
Mean Rec. 2.31 2.21 2.21 2.40
Latest Dividend: 0.39
Latest Dividend Yield: 2.72%
Dividend Ex-Date: 07/05/17
Price Earnings Ratio: 19.91
Price Earnings Comparisons:
BMY Sector Avg. S&P 500
19.91 19.90 30.50
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
1.56% -22.03% 18.00%
GROWTH 12 Mo 3 Yr CAGR
Revenue 17.30 0.20 0.06
Net Income 176.30 0.80 0.20
EPS 184.90 0.70 0.19
Earnings for BMY:
EBITDA 5.01B
Revenue 19.43B
Average Earnings Estimates
Qtr (06/17) Qtr (09/17) FY (12/17) FY (12/18)
Average Estimate $0.74 $0.75 $2.94 $3.06
Number of Analysts 8 7 11 10
High Estimate $0.76 $0.78 $2.97 $3.20
Low Estimate $0.72 $0.71 $2.87 $2.77
Prior Year $0.69 $0.77 $2.83 $2.94
Growth Rate (Year over Year) 6.70% -3.15% 3.76% 4.04%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
RMPIA
By

Jim Cramer

 | Jun 23, 2017 | 6:37 AM EDT
It just isn't as useful or descriptive right now.
By

Jim Cramer

 | Jun 16, 2017 | 5:58 AM EDT
A rotation that started as the minor chord of the rotational symphony and is now the major one.
By

Skip Raschke

 | Jun 12, 2017 | 8:30 AM EDT
I prefer a bullishly biased vertical call spread.
RMPIA
By

Jim Cramer

 | Jun 12, 2017 | 6:15 AM EDT
We really want to shake out the weak hands here.
RMPIA
By

Jim Cramer

 | Jun 7, 2017 | 7:29 AM EDT
The handwringers will be out in full force. Their fear creates buying opportunities.
RMPIA
By

Jim Cramer

 | May 16, 2017 | 12:30 PM EDT
What's right for a hedge fund manager sitting on a big gain, isn't necessarily right for you.

bearishBristol-Myers Cut to Underperform at BMO

May 3, 2017 | 9:08 AM EDT
Bristol-Myers was cut to "Underperform" at BMO with a $47 price target.

bearishBristol-Myers Cut to Underperform at BMO

May 3, 2017 | 9:08 AM EDT
Bristol-Myers was cut to "Underperform" at BMO with a $47 price target.
By

Bret Jensen

 | Apr 28, 2017 | 4:01 PM EDT
Let the weekend begin and may Day 2 and 3 of the NFL draft bring my Arizona Cardinals some undervalued gems on both sides of the bay. Great filling for Doug Kass over the past couple of days. Look forward to doing it again.
RMPIA
By

Jim Cramer

 | Apr 27, 2017 | 3:48 PM EDT
It doesn't look like Washington will be much help.

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.